88 results
424B5
SEEL
Seelos Therapeutics Inc
30 Nov 23
Prospectus supplement for primary offering
4:58pm
and hire additional personnel in order to successfully administer and manage our clinical trials and other studies as planned, which may result in delays … agencies could hinder their ability to hire and retain key leadership and other personnel, properly administer drug innovation, or prevent our
424B5
SEEL
Seelos Therapeutics Inc
28 Nov 23
Prospectus supplement for primary offering
4:06pm
and hire additional personnel in order to successfully administer and manage our clinical trials and other studies as planned, which may result in delays … agencies could hinder their ability to hire and retain key leadership and other personnel, properly administer drug innovation, or prevent our product
424B5
0iixt r3o
25 Sep 23
Prospectus supplement for primary offering
6:02am
424B5
b6yciv oxsf97fepnll6
12 May 22
Prospectus supplement for primary offering
8:30am
8-K
EX-10.2
o6i4zyale1uvmwi94j
24 Nov 21
Entry into a Material Definitive Agreement
7:27am
8-K
EX-1.1
su3qdin
21 May 21
Seelos Therapeutics Announces Pricing of $60 Million Public Offering of Common Stock
12:00am
424B5
oyvv1xvl9
21 May 21
Prospectus supplement for primary offering
12:00am
424B5
huks8t08jf11 bfr
19 May 21
Prospectus supplement for primary offering
4:08pm